Overbought Stocks
TOI appears in our Overbought Stocks screen, meaning it has experienced strong recent gains and may be trading at extended levels that could lead to short-term consolidation or pullback.
ONCOLOGY INSTITUTE INC/THE (TOI) Stock Price & Overview
NASDAQ:TOI • US68236X1000
Current stock price
4.05 USD
+0.19 (+4.92%)
At close:
4.05 USD
0 (0%)
After Hours:
The current stock price of TOI is 4.05 USD. Today TOI is up by 4.92%. In the past month the price increased by 29.81%. In the past year, price increased by 44.64%.
TOI Key Statistics
52-Week Range2.015 - 4.88
Current TOI stock price positioned within its 52-week range.
1-Month Range2.94 - 4.145
Current TOI stock price positioned within its 1-month range.
- Market Cap
- 400.302M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.52
- Dividend Yield
- N/A
TOI Stock Performance
Today
+4.92%
1 Week
+24.62%
1 Month
+29.81%
3 Months
+49.45%
Longer-term
6 Months -9.19%
1 Year +44.64%
2 Years +719.51%
3 Years +847.37%
5 Years N/A
10 Years N/A
TOI Stock Chart
TOI Stock Screens
TOI currently appears in the following ChartMill screener lists.
TOI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 89.14% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
TOI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TOI. TOI may be in some trouble as it scores bad on both profitability and health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TOI Earnings
On March 12, 2026 TOI reported an EPS of -0.06 and a revenue of 141.96M. The company beat EPS expectations (33.99% surprise) and beat revenue expectations (0.56% surprise).
Next Earnings DateMay 13, 2026
Last Earnings DateMar 12, 2026
PeriodQ4 / 2025
EPS Reported-$0.06
Revenue Reported141.957M
EPS Surprise 33.99%
Revenue Surprise 0.56%
TOI Forecast & Estimates
8 analysts have analysed TOI and the average price target is 7.14 USD. This implies a price increase of 76.3% is expected in the next year compared to the current price of 4.05.
For the next year, analysts expect an EPS growth of 45.62% and a revenue growth 29.42% for TOI
Analysts
Analysts82.5
Price Target7.14 (76.3%)
EPS Next Y45.62%
Revenue Next Year29.42%
TOI Index Membership
TOI is currently included in the following stock indexes tracked on ChartMill.
TOI Financial Highlights
Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS increased by 20.34% compared to the year before.
Income Statements
Revenue(TTM)502.73M
Net Income(TTM)-50.26M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.53% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%55.77%
Sales Q2Q%41.58%
EPS 1Y (TTM)20.34%
Revenue 1Y (TTM)27.79%
TOI Ownership
Ownership
Inst Owners44.77%
Shares98.84M
Float78.25M
Ins Owners15.14%
Short Float %10.32%
Short Ratio4.45
TOI Industry Overview
TOI operates in the Health Care Facilities sub-industry within the Health Care sector. This group contains 19 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
61/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
64/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
49%
Outperformed 49% of sub-industries
3 Month Rank
58%
Outperformed 58% of sub-industries
6 Month Rank
60%
Outperformed 60% of sub-industries
Industry Fundamentals & Breadth
- Members
- 19
- New Highs
- 10.5%
- New Lows
- 0%
- Average ROE
- 22.8%
- Average Profit Margin
- 8.1%
- Average Operating Margin
- 14.3%
- Average P/E
- 15.5
- Average Fwd P/E
- 14.2
- Average Debt/Equity
- 1.7
TOI Competitors/Peers
The largest stocks on the US markets in the "Health Care Facilities" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 12.86 | 97.13B | ||
| THC | TENET HEALTHCARE CORP | 10.26 | 15.402B | ||
| ENSG | ENSIGN GROUP INC/THE | 23.96 | 10.905B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 6.47 | 10.27B | ||
| EHC | ENCOMPASS HEALTH CORP | 16.44 | 9.942B | ||
| PACS | PACS GROUP INC | 15.26 | 5.273B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 3.415B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.33 | 2.888B | ||
| NHC | NATIONAL HEALTHCARE CORP | N/A | 2.703B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 16.14 | 2.383B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 11.92 | 2.035B | ||
| SGRY | SURGERY PARTNERS INC | 58.29 | 1.816B | ||
| SNDA | SONIDA SENIOR LIVING INC | N/A | 1.799B |
Related stock screener links
View all stocks in the Health Care Facilities Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TOI
Company Profile
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company Info
IPO: 2020-03-13
ONCOLOGY INSTITUTE INC/THE
18000 Studebaker Rd, Suite 800
Cerritos CALIFORNIA US
CEO: Steven Hochberg
Employees: 641
Phone: 15627353226
ONCOLOGY INSTITUTE INC/THE / TOI FAQ
Can you describe the business of ONCOLOGY INSTITUTE INC/THE?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Can you provide the latest stock price for ONCOLOGY INSTITUTE INC/THE?
The current stock price of TOI is 4.05 USD. The price increased by 4.92% in the last trading session.
What is the dividend status of ONCOLOGY INSTITUTE INC/THE?
TOI does not pay a dividend.
What is the ChartMill rating of ONCOLOGY INSTITUTE INC/THE stock?
TOI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in ONCOLOGY INSTITUTE INC/THE be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TOI.
What is the next earnings date for TOI stock?
ONCOLOGY INSTITUTE INC/THE (TOI) will report earnings on 2026-05-13.